Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Penicillin G Acyl-Serine is an experimental small molecule related to the penicillin class of antibiotics. It is not approved for clinical use in any country and has no known brand names or marketed formulations. The compound's structure suggests it is a derivative or analog of penicillin G (benzylpenicillin), possibly designed to interact with bacterial cell wall synthesis pathways, similar to other β-lactam antibiotics. However, there are no published indications, clinical trials, or detailed pharmacological data available for this specific molecule[2]. Its mechanism likely involves inhibition of bacterial cell wall biosynthesis by targeting penicillin-binding proteins (PBPs), as with other penicillins[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Penicillin G Acyl-Serine.